In Canada, Ceapro announced the signing of a Loan Agreement with its major partner, Symrise, a German-based multinational company. “This significant financial support from Symrise fully provides Ceapro with the required capital to complete the construction and implementation of the state of the art facility in Edmonton,” said Gilles Gagnon, President and CEO of Ceapro.
Ceapro, a Canadian biotechnology company, focuses on business activities related to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. No details of the loan were released at this time.
More on the story.
